These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Cervical duplex ultrasound for the diagnosis of giant cell arteritis with vertebral artery involvement. Kargiotis O; Psychogios K; Safouris A; Bakola E; Andreadou E; Karapanayiotides T; Finitsis S; Palaiodimou L; Giannopoulos S; Magoufis G; Tsivgoulis G J Neuroimaging; 2021 Jul; 31(4):656-664. PubMed ID: 33817861 [TBL] [Abstract][Full Text] [Related]
24. Positron emission tomography assessment of large vessel inflammation in patients with newly diagnosed, biopsy-proven giant cell arteritis: a prospective, case-control study. Prieto-González S; Depetris M; García-Martínez A; Espígol-Frigolé G; Tavera-Bahillo I; Corbera-Bellata M; Planas-Rigol E; Alba MA; Hernández-Rodríguez J; Grau JM; Lomeña F; Cid MC Ann Rheum Dis; 2014 Jul; 73(7):1388-92. PubMed ID: 24665112 [TBL] [Abstract][Full Text] [Related]
25. Diagnostic value of axillary artery ultrasound in patients with suspected giant cell arteritis. Hop H; Mulder DJ; Sandovici M; Glaudemans AWJM; van Roon AM; Slart RHJA; Brouwer E Rheumatology (Oxford); 2020 Dec; 59(12):3676-3684. PubMed ID: 32240306 [TBL] [Abstract][Full Text] [Related]
26. Role of positron emission tomography in the assessment of disease burden and risk of relapse in patients affected by giant cell arteritis. Bellan M; Puta E; Croce A; Sacchetti GM; Orsini F; Zecca E; Soddu D; Gavelli F; Avanzi GC; Castello L; Pedrazzoli R; Sola D; Pirisi M; Sainaghi PP Clin Rheumatol; 2020 Apr; 39(4):1277-1281. PubMed ID: 31713732 [TBL] [Abstract][Full Text] [Related]
27. Positron emission tomography and computed tomography angiography for the diagnosis of giant cell arteritis: A real-life prospective study. Lariviere D; Benali K; Coustet B; Pasi N; Hyafil F; Klein I; Chauchard M; Alexandra JF; Goulenok T; Dossier A; Dieude P; Papo T; Sacre K Medicine (Baltimore); 2016 Jul; 95(30):e4146. PubMed ID: 27472684 [TBL] [Abstract][Full Text] [Related]
28. The clinical benefit of imaging in the diagnosis and treatment of giant cell arteritis. Berger CT; Sommer G; Aschwanden M; Staub D; Rottenburger C; Daikeler T Swiss Med Wkly; 2018 Aug; 148():w14661. PubMed ID: 30141518 [TBL] [Abstract][Full Text] [Related]
29. [18F]FDG positron emission tomography in patients presenting with suspicion of giant cell arteritis-lessons from a vasculitis clinic. Imfeld S; Rottenburger C; Schegk E; Aschwanden M; Juengling F; Staub D; Recher M; Kyburz D; Berger CT; Daikeler T Eur Heart J Cardiovasc Imaging; 2018 Aug; 19(8):933-940. PubMed ID: 29126277 [TBL] [Abstract][Full Text] [Related]
30. Red flags for a concomitant giant cell arteritis in patients with vertebrobasilar stroke: a cross-sectional study and systematic review. Elhfnawy AM; Elsalamawy D; Abdelraouf M; Schliesser M; Volkmann J; Fluri F Acta Neurol Belg; 2020 Dec; 120(6):1389-1398. PubMed ID: 32323167 [TBL] [Abstract][Full Text] [Related]
34. Distribution patterns of arterial affection and the influence of glucocorticoids on Malich L; Gühne F; Hoffmann T; Malich A; Weise T; Oelzner P; Wolf G; Freesmeyer M; Pfeil A RMD Open; 2022 Aug; 8(2):. PubMed ID: 35953239 [TBL] [Abstract][Full Text] [Related]
35. Takayasu arteritis and large-vessel giant cell arteritis in Italian population. Comprehensive analysis from a single institutional cohort of 184 cases. Boiardi L; Galli E; Macchioni P; Muratore F; Klinowski G; Hunder GG; Casali M; Besutti G; Spaggiari L; Versari A; Croci S; Mancuso P; Rossi PG; Marvisi C; Salvarani C Semin Arthritis Rheum; 2023 Apr; 59():152173. PubMed ID: 36780709 [TBL] [Abstract][Full Text] [Related]
36. Positron Emission Tomography/Computerized Tomography in Newly Diagnosed Patients with Giant Cell Arteritis Who Are Taking Glucocorticoids. Clifford AH; Murphy EM; Burrell SC; Bligh MP; MacDougall RF; Heathcote JG; Castonguay MC; Lee MS; Matheson K; Hanly JG J Rheumatol; 2017 Dec; 44(12):1859-1866. PubMed ID: 28916549 [TBL] [Abstract][Full Text] [Related]
37. Performance of the new 2022 ACR/EULAR classification criteria for giant cell arteritis in clinical practice in relation to its clinical phenotypes. Narváez J; Estrada P; Vidal-Montal P; Nolla JM Autoimmun Rev; 2023 Oct; 22(10):103413. PubMed ID: 37598876 [TBL] [Abstract][Full Text] [Related]
38. Diagnostic performance of Hay B; Mariano-Goulart D; Bourdon A; Benkiran M; Vauchot F; De Verbizier D; Ben Bouallègue F Ann Nucl Med; 2019 Jul; 33(7):512-520. PubMed ID: 30976984 [TBL] [Abstract][Full Text] [Related]
39. Management of large-vessel vasculitis with FDG-PET: a systematic literature review and meta-analysis. Soussan M; Nicolas P; Schramm C; Katsahian S; Pop G; Fain O; Mekinian A Medicine (Baltimore); 2015 Apr; 94(14):e622. PubMed ID: 25860208 [TBL] [Abstract][Full Text] [Related]
40. Giant-cell arteritis: concordance study between aortic CT angiography and FDG-PET/CT in detection of large-vessel involvement. de Boysson H; Dumont A; Liozon E; Lambert M; Boutemy J; Maigné G; Martin Silva N; Sultan A; Ly KH; Aide N; Manrique A; Bienvenu B; Aouba A Eur J Nucl Med Mol Imaging; 2017 Dec; 44(13):2274-2279. PubMed ID: 28736805 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]